RT Journal Article SR Electronic T1 Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene Mutations JF Ochsner Journal JO Ochsner J FD O. P. Jindal Global University DO 10.31486/toj.23.0119 A1 Badve, Shivani B. A1 Kim, Emily A1 Sibia, Udai S. A1 Borrego, Orestes T. A1 Vara, Stephen A1 Damron, Alexander A1 Riker, Adam I. YR 2024 UL http://www.ochsnerjournal.org/content/early/2024/01/24/toj.23.0119.abstract AB Background: Male breast cancer remains relatively underexplored in the medical literature. At present, male patients with breast cancer follow the same treatment guidelines as female patients with breast cancer, principally because of similar outcomes with treatment. However, this practice should not preclude generating evidence for male breast cancer surveillance, diagnosis, and management. BRCA2 gene mutations are associated with an increased risk of male breast cancer, along with lesser-known gene mutations that could also increase this risk, such as mutations of the BRIP1 gene. This case report presents a male patient with dual BRCA2 and BRIP1 deleterious gene mutations. To our knowledge, this combination has not been reported in the medical literature to date.Case Report: A 53-year-old male presented with a palpable symptomatic mass underneath the right nipple-areolar complex. Biopsies confirmed a poorly differentiated, infiltrating ductal carcinoma that was estrogen and progesterone receptor positive and human epidermal growth factor receptor-2 negative. The patient underwent a left modified radical mastectomy, with a right prophylactic simple mastectomy. Postoperatively, he underwent adjuvant chemotherapy and endocrine therapy.Conclusion: This novel case of genetically based male breast cancer with dual deleterious gene mutations provides insight into current treatment recommendations and the subtle differences between male breast cancer and female breast cancer. Engaging in discussions surrounding such rare cases not only raises awareness of male breast cancer but also indicates the need for further research aimed at establishing evidence-based management strategies for male patients with breast cancer.